Scailyte AG
PrivateLast Round
Series A
Extension
Dec 4, 2023
Total Funding Raised
$14.88M
Company Overview
Scailyte AG operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Series A Extension round in December 2023.
Scailyte AG is a biotechnology company that provides an artificial intelligence platform for the discovery of complex disease patterns from single-cell data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scailyte AG Comparables
Compare Scailyte AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abiosciences | 89% | |
| One Biosciences | 86% | |
| Nucleai | 85% |
For institutional investors. Book with your work email.
Scailyte AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 4, 2023 | ||||
| Grant | Nov 11, 2022 | ||||
| Series A | Sep 21, 2022 | ||||
| Seed | Jun 9, 2020 | ||||
| Seed | Dec 19, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Scailyte AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Swisscom Ventures | Series A, Seed |
| 4FOX Ventures | Series A, Seed |
| Venture Kick | Grant |
| Mirabaud Securities | Series A |
| Zurcher Kantonalbank | Series A, Seed |
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors increased 136% MoM, reaching 2.6K.
- Nov 14, 2024
Monthly visitors increased 98% MoM.
For institutional investors. Book with your work email.
Scailyte AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Scailyte AG's valuation, stock price, and market status.
Is Scailyte AG a public or private company?
Scailyte AG is a private company.
What is the current stock price of Scailyte AG?
Scailyte AG is a private company, so its shares have no public market price. Caplight tracks Scailyte AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scailyte AG worth (valuation)?
Valuation information for Scailyte AG is not publicly available.
Can I buy Scailyte AG stock?
Scailyte AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scailyte AG's last funding round?
Scailyte AG's most recent funding round was Series A Extension on December 4, 2023.
Who are the main investors in Scailyte AG?
Key investors in Scailyte AG include Swisscom Ventures, Mirabaud Securities.
Will Scailyte AG IPO soon?
No public IPO plans have been announced for Scailyte AG.
How can I track Scailyte AG secondary market activity?
Caplight tracks bids, offers, and trades in Scailyte AG's shares on secondary markets.